BACKGROUND/AIM: The consensus document for @entity56 to nonsteroidal anti-inflammatory drugs (NSAIDs) proposed by the European Network for @entity56 (ENDA) interest group (2011) was revised in 2013. We aimed to evaluate the usability of the latest NSAID @entity56 classification of ENDA. METHOD: A total of 370 @entity1 with a history of @entity56 to NSAIDs among the 1250 outpatients referred for suspected @entity56 between July 2013 and June 2014 were evaluated, and 308 @entity1 who were confirmed as having NSAID @entity56 were included in this study. After confirming the diagnosis, a single-blind placebo-controlled drug provocation test was performed with @entity117 or @entity3522 to categorize the @entity1 according to the ENDA classification. The reactions not meeting the ENDA classification criteria were grouped as blended reactions. RESULTS: Among the 308 @entity1 (224 female, mean age 42.12    13.24), the leading cause of @entity56 was metamizol (30.5%) followed by @entity117 (30.2%). The most common NSAID @entity56 subgroup was SNIUAA (46.4%) and the least common type was SNIDR (1.6%). Cross-reactivity was identified in 50.3% of the @entity1 . In five @entity1 (1.6%), the @entity56 to NSAIDs did not meet the ENDA classification: Three @entity1 experienced @entity2021 with different NSAIDs, one @entity1 encountered @entity2021 with one NSAID and @entity110 with other NSAIDs, and the last @entity1 had @entity113 with different NSAIDs. CONCLUSION: The latest ENDA classification for NSAID @entity56 is generally a practical and useful instrument for clinicians. We only point out that @entity2021 with different NSAIDs can be seen in a small group of @entity1 .

Evaluation of XXXX to nonsteroidal anti-inflammatory drugs according to the latest classification.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity3522 :: ('MESH:D004008', 'Chemical') :: ['diclofenac'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity56 :: ('MESH:D004342', 'Disease') :: ['Drug Allergy', 'drug allergy', 'hypersensitivity reactions', 'hypersensitivity'] @entity113 :: ('MESH:D000799', 'Disease') :: ['angioedema'] @entity110 :: ('MESH:D014581', 'Disease') :: ['urticaria'] @entity2021 :: ('MESH:D000707', 'Disease') :: ['anaphylaxis']
@entity56 :: (MESH:D004342,Disease) :: ['hypersensitivity reactions']
